Investor Presentaiton
32
IFRS17 programme well advanced
Expected outcomes
Strategy and dividend policy
unchanged
• Value and capital metrics
unchanged
Reconciliation of Shareholders'
Equity plus CSM to EEV will
be provided
• Accounting mismatches remain
Operating profit will separate
short-term fluctuations from
underlying earnings
Opening
Balance Sheet
(1 Jan 2022)
UK endorsed
IFRS17
(17 May 2022)
2022
IFRS17 comparative period
·
In progress
Key accounting judgements
agreed, subject to external audit
Production and audit of Opening
Balance Sheet underway
•
Outstanding
Some judgements pending
industry developments
External audit of accounting
policies, new processes and
controls
⚫ HY22 IFRS17 comparatives
production to start in Q3 2022
2023
IFRS17
Effective Date
(1 Jan 2023)
FY22 on
IFRS4 with
guidance
on IFRS17
impacts
(Mar 2023)
Market
briefing
on IFRS
17 results
(Q2 2023)
HY23 interims on
IFRS17 basis
(Aug 2023)
FY23 with full
IFRS17
disclosures
(Mar 2024)
2024View entire presentation